BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29722330)

  • 1. Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease.
    Chen M; Du ZY; Zheng X; Li DL; Zhou RP; Zhang K
    Neural Regen Res; 2018 Apr; 13(4):742-752. PubMed ID: 29722330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain alterations in the early Alzheimer's continuum with amyloid-β, tau, glial and neurodegeneration CSF markers.
    Salvadó G; Shekari M; Falcon C; Operto G; Milà-Alomà M; Sánchez-Benavides G; Cacciaglia R; Arenaza-Urquijo E; Niñerola-Baizán A; Perissinotti A; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Molinuevo JL; Zetterberg H; Blennow K; Suárez-Calvet M; Gispert JD;
    Brain Commun; 2022; 4(3):fcac134. PubMed ID: 35702732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of curcumin-based fluorescent probes to detect Aβ fibrils.
    Sato T; Hotsumi M; Makabe K; Konno H
    Bioorg Med Chem Lett; 2018 Dec; 28(22):3520-3525. PubMed ID: 30297285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
    Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
    Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin Scaffold as a Multifunctional Tool for Alzheimer's Disease Research.
    Yang H; Zeng F; Luo Y; Zheng C; Ran C; Yang J
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35745002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity.
    Weigand AJ; Bangen KJ; Thomas KR; Delano-Wood L; Gilbert PE; Brickman AM; Bondi MW;
    Brain Commun; 2020; 2(1):fcz046. PubMed ID: 32051933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of curcumin (turmeric) on Alzheimer's disease: An overview.
    Mishra S; Palanivelu K
    Ann Indian Acad Neurol; 2008 Jan; 11(1):13-9. PubMed ID: 19966973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).
    Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L
    Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease.
    Reddy PH; Manczak M; Yin X; Grady MC; Mitchell A; Kandimalla R; Kuruva CS
    J Investig Med; 2016 Dec; 64(8):1220-1234. PubMed ID: 27521081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Rodriguez JL; Snellman A; Suárez-Calvet M; Zetterberg H; Blennow K; Schöll M;
    Brain; 2021 Feb; 144(1):325-339. PubMed ID: 33257949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Possible Therapeutic Role of Curcumin.
    Pluta R; Furmaga-Jabłońska W; Januszewski S; Czuczwar SJ
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective.
    Shokouhi S; Campbell D; Brill AB; Gwirtsman HE;
    Brain Pathol; 2016 Sep; 26(5):664-71. PubMed ID: 27327527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET and amyloid-PET imaging: the diverging paths.
    Perani D
    Curr Opin Neurol; 2014 Aug; 27(4):405-13. PubMed ID: 24927239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.
    Sundaram JR; Poore CP; Sulaimee NHB; Pareek T; Cheong WF; Wenk MR; Pant HC; Frautschy SA; Low CM; Kesavapany S
    J Alzheimers Dis; 2017; 60(4):1429-1442. PubMed ID: 29036814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease.
    Maiti P; Paladugu L; Dunbar GL
    BMC Neurosci; 2018 Feb; 19(1):7. PubMed ID: 29471781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.